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Heme Reversibly Damps PERIOD2 Rhythms in Mouse
Suprachiasmatic Nucleus Explants
Casey J. Guenthner1, David Bickar2, and Mary E. Harrington1,*
1Department of Psychology and Program in Neuroscience, Smith College, Northampton, MA
2Department

of Biochemistry and Program in Neuroscience, Smith College, Northampton, MA

Abstract
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The hypothalamic suprachiasmatic nucleus (SCN), which in mammals serves as the master circadian
pacemaker by synchronizing autonomous clocks in peripheral tissues, is composed of coupled singlecell oscillators that are driven by interlocking positive/negative transcriptional/translational feedback
loops. Several studies have suggested that heme, a common prosthetic group that is synthesized and
degraded in a circadian manner in the SCN, may modulate the function of several feedback loop
components, including the REV-ERB nuclear receptors and PERIOD2 (PER2). We found that ferric
heme (hemin, 3-100 μM) dose-dependently and reversibly damped luminescence rhythms in SCN
explants from mice expressing a PER2∷LUCIFERASE (PER2∷LUC) fusion protein. Inhibitors of
heme oxygenases (HOs, which degrade heme to biliverdin, carbon monoxide, and iron) mimicked
heme’s effects on PER2 rhythms. In contrast, heme and HO inhibition did not damp luminescence
rhythms in thymus and esophagus explants and had only a small effect on PER2∷LUC damping in
spleen explants, suggesting that heme’s effects are tissue-specific. Analysis of the effects of heme’s
degradation products on SCN PER2∷LUC rhythms indicated that they probably were not responsible
for heme’s effects on rhythms. The heme synthesis inhibitor N-methylprotoporphyrin IX (NMP)
lengthened the circadian period of SCN PER2∷LUC rhythms by about an hour. These data are
consistent with an important role for heme in the circadian system.
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In mammals, circadian rhythms in physiology and behavior are generated by a master
pacemaker in the hypothalamic suprachiasmatic nucleus (SCN), which is composed of
thousands of coupled single-cell oscillators (Welsh et al., 1995, Yamaguchi et al., 2003).
Rhythms in individual cells are sustained by a series of interacting positive and negative
transcriptional/translational feedback loops (Ko and Takahashi, 2006). Among these,
CLOCK:BMAL1 and NPAS2:BMAL1 heterodimers drive transcription of the Period
(mPer1-3 in mice) and Cryptochrome (mCry1-2 in mice) genes and of the genes for the nuclear
receptors REV-ERBα (NR1D1) and REV-ERBβ (NR2D2); the mCRYs and mPERs then feed
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back to inhibit CLOCK:BMAL1- and NPAS2:BMAL1-mediated transcription while the REVERBs repress Bmal1 expression.
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While models of the molecular basis of circadian rhythms have focused primarily on these
transcriptional/translational feedback loops, small cytosolic signaling molecules, such as
Ca2+ and cAMP, have recently emerged as fundamental components of the circadian clock
mechanism (Ikeda et al., 2003, Lundkvist et al., 2005, Hastings et al., 2008, O’Neill et al.,
2008). Heme, an ubiquitous molecule that is synthesized in virtually every cell in the body,
has long been considered essential for normal cellular function, since it acts as a prosthetic
group for several proteins involved in a broad range of physiological processes (Wagener et
al., 2003). The recent finding that heme functions as a reversible REV-ERB ligand to repress
transcription of REV-ERB target genes (Raghuram et al., 2007, Yin et al., 2007) suggests that
heme may also act as a signaling molecule, and, more specifically, as a cytosolic regulator of
the circadian clock. Consistent with this idea, heme application phase-shifted the electrical
activity rhythm in acute SCN slices (Artinian et al., 2001) and peripheral heme administration
altered clock gene expression in mouse liver (Kaasik and Lee, 2004). Additionally, hemin
treatment has been shown to synchronize clock gene expression in mouse fibroblasts (Kaasik
and Lee, 2004, Rogers et al., 2008).
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We investigated if heme homeostasis is necessary for normal circadian clock function in mouse
tissue explants and found that pharmacologically elevating intracellular heme levels reversibly
and dose-dependently damps PER2∷LUCIFERASE rhythms in the SCN. These data are
consistent with an important role for heme in the mammalian circadian clock.

EXPERIMENTAL PROCEDURES
Animals
Male and female heterozygous (mPer2Luc/+) and homozygous (mPer2Luc/Luc)
mPER2∷LUCIFERASE knockin mice (Yoo et al., 2004) were drawn from an in-house colony
(derived from founders generously provided by Joseph Takahashi, Northwestern University)
and were housed in a 12 h:12 h light:dark cycle prior to dissection. All animal protocols were
approved by the Smith College Institutional Animal Care and Use Committee.
Tissue Preparation
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SCN and peripheral tissue explants were prepared according to standard methods (Yoo et al.,
2004). Subjects were overdosed with halothane or isoflurane anesthesia, and 300 m coronal
sections through the SCN were cut on a vibratome (Campden Istruments, Lafayette, IN) in
chilled Hank’s balanced salt solution (Invitrogen, Carlsbad, CA). Sections were trimmed by
hand to the SCN and immediately surrounding tissue and were transferred to culture inserts
(Millipore, Billerica, MA) in 35 mm dishes [BD Falcon (Franklin Lakes, NJ) or Electron
Microscopy Sciences, (Hatfield, PA)]. Peripheral tissues were trimmed by hand to
approximately 1-8 mm3 and were cultured on nylon mesh (Small Parts, Miami Lake, FL).
Dishes contained 1.0 mL-1.2 mL Dulbecco’s modified Eagle’s medium (Sigma-Aldrich, St.
Louis, MO) supplemented with 1X B-27 (Invitrogen), 4 mM L-glutamine (Invitrogen), 25 mM
glucose (Sigma), 4.2 mM NaHCO3 (Sigma), 10 mM HEPES (Sigma), 25 Units/mL penicillin
G sodium (Invitrogen), 34 μM streptomycin sulfate (Invitrogen), and 100 μM beetle luciferin
(Promega, Madison, WI). Dishes were sealed with hot glue (for CO experiments) or with
vacuum grease (Dow, Midland, MI; for all other experiments). As many as two SCN sections
and four peripheral tissue sections (per tissue type) were collected from a single animal;
multiple samples of the same tissue from a single animal were placed in different treatment
groups.
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Drug Treatments
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Biliverdin hydrochloride, hemin chloride, tin protoporphyrin IX, protoporphyrin IX, and Nmethylprotoporphyrin IX (all from Sigma or Frontier) were dissolved in sterile 0.085 M or
0.17 M Na3PO4 (Sigma). Ferrous ammonium sulfate [Fe(NH4)2(SO4)2] was dissolved in sterile
water. Ketoconazole (Sigma) was dissolved in DMSO. Lipopolysaccharide (Sigma) was
dissolved in Hank’s balanced salt solution. Tumor necrosis factor α (TNFα; Peprotech, Rocky
Hill, NJ) was dissolved in water. Drugs were diluted 500-fold (ketoconazole), 10,000-fold
(lipopolysaccharide), 2000-fold (TNFα), or 1000-fold (all other drugs) into culture media at
the time of dissection. For all porphyrin treatments, the final Na3PO4 concentration was 170
μM, which did not change the initial pH of the media or the media’s pH after a week in culture
(data not shown). Carbon monoxide was measured, mixed with air, and delivered using gastight syringes (Hamilton, Reno, NV). To produce equilibrium aqueous CO concentrations of
30 μM and 100 μM, 50 mL of 4%:96% and 13%:87% (v/v) CO:Air mixtures (see R. Sander,
http://www.henrys-law.org), respectively, were flushed through a hole in the top of each presealed culture dish before rapidly sealing the hole with hot glue; in preliminary experiments,
this procedure resulted in minimal CO leakage from culture dishes over the course of a week
(data not shown). For all treatment groups, tissues were washed three times with control media
5-8 days after dissection, and bioluminescence monitoring was continued.
Bioluminescence Monitoring
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Integrated bioluminescence was recorded for 60 s every 10 min using a commercial
luminometer (LumiCycle, Actimetrics, Wilmette, IL) housed in an air incubator at 35.8 °C.
Data Analysis
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Data from the dissection day (Day 0) and from the days with media changes were excluded
from analysis because of transient luminescence spikes. Data were baseline-subtracted with a
24 h running average and smoothed with a 2 h running-median filter. Rhythmicity indices (RIs;
defined as the first peak after lag = 0 of the autocorrelation function) calculated for the first
three cycles in vitro and for the first three cycles following the media change were used to
classify arrhythmic cultures (Levine et al., 2002), which were excluded from subsequent
analysis (Supplemental Table). Damped sine curves [Y(t) = A sin (2πt/P-t0) • e-td/24] were fit
to pre-wash data to obtain the damping constant (d) and to 3-day pre- and post-wash segments
to obtain the circadian period (P). All analyses were performed using Lumicycle Analysis
(Actimetrics), SPSS, and custom-written software. The no-drug and Na3PO4 + DMSO control
groups had statistically similar damping constants (t(22) = 0.332, p = .743) and post-media
change RIs (t(22) = 0.972, p = .342), so they were combined into a single control group for
subsequent analysis. In addition, no-drug and Na3PO4 + DMSO tissues collected on five
different runs had similar damping constants (F(4,14) = 0.982, p = .449), suggesting that our
run-to-run consistency was sufficient to enable us to compare samples collected on different
days. Controls cultured under the conditions used for CO treatment (“Air” controls) damped
more quickly (t(28) = -2.611, p = .014) and had lower post-media change RIs (t(28) = 2.393, p
= .024) than controls cultured under the conditions used in the other experiments, so those
groups are analyzed separately. Damping constants and rhythmicity indices were analyzed with
one-way ANOVAs followed by Tukey’s HSD; the treatment groups included in a particular
analysis are those presented in the corresponding figure.

RESULTS
Heme reversibly and dose-dependently damps SCN PER2∷LUCIFERASE rhythms
Control SCN cultures (0 μM heme) exhibited stable and robust circadian bioluminescence
rhythms in vitro (Figs. 1A and 1B, top panels), while the amplitude of rhythms in slices treated
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with heme (administered as hemin chloride in the culture media immediately following
dissection) decreased gradually over a period of several days (Figs. 1A and 1B, lower panels).
The baseline-to-peak rhythm amplitude of each cycle, normalized to the peak on the day
following dissection (cycle 1) decreased more rapidly in heme-treated cultures than in control
cultures (Fig. 1C; treatment, F(3,51) = 15.18, p < .001; treatment × cycle, F(12,204) = 8.289, p
< .001). To further quantify this effect, we fit damped sine curves to the baseline-subtracted
data (Fig. 1B), and extracted from the fit curve the component (called the damping constant)
that determines how rapidly rhythm amplitude decreases over time. Heme dose-dependently
increased the damping constant (Fig. 1D; 30 vs. 100, p = .419; all other comparisons, p’s < .
05). To verify that the effect of heme on rhythm damping was not merely due to heme toxicity,
we washed tissue and replaced heme-containing media with control media six to eight days
after dissection (indicated by arrows in Fig. 1A). This media change restored rhythm robustness
in heme-treated cultures (quantified using rhythmicity indices; Table 1; RI, F(3,51) = 0.765, p
= .519), indicating that heme’s effects were reversible.
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To determine whether heme treatment affected overall luminescence levels, we fit 24 h running
average baselines to raw bioluminescence traces (Fig. 2A) and calculated the average
normalized baseline for each treatment group (Fig. 2B; the 100 μM group was excluded from
this analysis due to small sample size). Heme decreased baseline luminescence after several
days, suggesting that heme may decrease mPER2 expression, but this effect did not appear to
be dose-dependent (Fig. 2B). Since raw luminescence of heme-treated SCNs typically
remained well above dark-count levels (~30 counts/s) even after a week of treatment (see Figure
1A), heme-mediated rhythm damping could not have been due to suppression of luminescence
to levels that rendered rhythms undetectable.
We also investigated whether heme’s effect could be due to a general effect of porphyrins.
SCNs treated with 30 μM protoporphyrin IX (PPIX), a molecule identical to heme but lacking
the central iron atom, did not damp more quickly than controls (Figs. 3 and S1; p = .971),
suggesting that heme’s effect on damping were not due to a general effect of porphyrins.
Heme oxygenase inhibition damps SCN PER2∷LUCIFERASE rhythms
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We also tested whether increasing the intracellular heme concentration indirectly via inhibition
of heme breakdown (Goodman et al., 2007) could also damp PER2∷LUC rhythms in the SCN.
The competitive HO inhibitor tin protoporphyrin IX (SnPP; (Drummond and Kappas, 1981)
and the non-competitive HO inhibitor ketoconazole (Keto; Kinobe et al., 2006), both damped
SCN PER2∷LUC rhythms relative to controls (Figs. 4 and S2; p’s < .05). Moreover, heme +
SnPP damped rhythms more quickly than heme or SnPP alone (p’s < .05), but a similar
combined effect was not observed for heme + keto (p’s > .940). In constrast, Keto but not SnPP
shortened the circadian period of SCN PER2∷LUC rhythms by about 1 h (Supplementary
Table). Following the media change, rhythms in cultures treated with keto or SnPP with or
without heme were as robust as those in control cultures (Table 1; two-way ANOVA, all p’s
> .05), indicating that the effects of those drugs were not due to irreversible toxicity.
The effects of heme and of HO inhibition are tissue-specific
In addition to the SCN, peripheral tissues throughout the body maintain rhythms of clock gene
expression (Yoo et al., 2004). We found no effect of 30 μM heme, 30 μM SnPP, or both together
on PER2∷LUC rhythms in esophagus or thymus explants (Figs. 5, S3, S4, and S6; two-way
ANOVAs, p’s > .182). We also tested the effect of a 100 μM heme on esophagus explants and
found no effect (Fig. S3 and S6 and data not shown). In contrast, spleen explants treated with
heme + SnPP damped more quickly than control spleen cultures (Figs. 5 and S5; control vs.
SnPP + heme, p = .008; heme vs. SnPP + heme, p = .085; all other comparisons, p’s > .360).
Analysis of cycle-to-cycle rhythm amplitude suggested that heme and SnPP alone might also
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have an effect on damping in spleen explants but not in thymus or esophagus explants (Fig.
S6). For all tissues, post-media change RIs were similar in all treatment groups (two-way
ANOVA, all p’s > .330), and we observed no effect of 30 μM heme on baseline luminescence
in any of the tissues tested (data not shown).
Effects of heme metabolites on PER2∷LUCIFERASE rhythms
To determine if the effects of heme and HO inhibitor treatments might be due to changes in
levels of the heme breakdown products, we applied each breakdown product individually to
SCN explants. Because CO treatments required different culture conditions than other
treatments (see Experimental Procedures), we analyzed biliverdin and iron groups (Figs. 6AB and S7) separately from CO groups (Figs. 6C-D and S8). PER2∷LUC rhythms in iron and
3 μM biliverdin groups damped at similar rates to the control group (p’s > .700), but a higher
dose of biliverdin (30 μM) accelerated rhythm damping (p < .001). None of the treatments
tested affected rhythm robustness following a medium change (Table 1; one-way ANOVA of
RI, F(4,52) = 0.164, p = .956).
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Control (“Air”) SCN slices cultured under conditions identical to those used for CO-treated
cultures damped more quickly and had less robust post-media change rhythms than SCNs
cultured under our original conditions, suggesting that the sealed culture conditions necessary
for CO treatment were detrimental to tissue health (Supplementary Table; see Experimental
Procedures). We found no effect of 30 μM or 100 μM CO on damping or post-wash rhythmicity
indices (damping constant, one-way ANOVA, F(2,18) = 0.168, p = .847; post-media change
RI, F(2,18) = 0.081, p = .923). At 300 μM, CO caused luminescence to drop irreversibly to darkcount levels after 2-4 days, consistent with tissue death (data not shown).
Inhibition of heme synthesis lengthens circadian period
Since treatments that increase intracellular heme levels disrupt PER2∷LUC rhythms, we
examined whether heme deficiency is also associated with abnormal rhythmicity. Nmethylprotoporphyrin IX (NMP) is an inhibitor of ferrochelatase, which catalyzes the last step
in heme synthesis, and has been used to induce heme deficiency in primary neuronal cultures
(Atamna et al., 2002). Neither 10 μM or 50 μM NMP increased the rate at which SCN
PER2∷LUC rhythms damped relative to controls (Fig. 7; Tukey’s HSD, p’s > .250), but the
difference in damping between 50 μM NMP and the 30 μM heme group only approached
significance (p = .058). However, NMP did significantly lengthen circadian period of
PER2∷LUC rhythms before (p = .012) but not after (p = .995) the media change (Supplementary
Table).
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Heme’s effects are not due to actions at toll-like receptor 4 (TLR4)
Recently, heme was reported to activate the lipopolysaccharide (LPS) receptor TLR4 to induce
tumor necrosis factor α (TNFα) secretion in cultured macrophages (Figueiredo et al., 2007).
To determine whether heme’s effects could be mediated by TLR4 activation and TNFα
secretion, we treated PER2∷LUC SCN explants with LPS (100 ng/mL) or TNFα (50 ng/mL).
We did not observe any effects of LPS on rhythm damping [mean damping constant ± SEM
for control (n = 4): 0.325 ± 0.037; for LPS (n = 4): 0.344 ± 0.052; t(6) = .307, p = .769] or
circadian period (data not shown). There were similarly no effects of TNFα [mean damping
constant ± SEM for control (n = 4): 0.327 ± 0.058; for TNFα (n = 4): 0.359 ± 0.055; t(6) =
0.406, p = .699]

DISCUSSION
We found that experimentally elevating heme levels, whether via direct application of
exogenous heme or via heme oxygenase inhibition, damps PER2∷LUC rhythms in the mouse
Neuroscience. Author manuscript; available in PMC 2010 December 1.
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SCN. The effects of exogenous heme on PER2∷LUC rhythms were dose-dependent in the
SCN. Heme and heme oxygenase inhibition also accelerate damping in spleen explants but not
in esophagus or thymus explants; thus, while heme’s effect is not specific to the central SCN
oscillator, it is tissue specific.
Interestingly, while the heme oxygenase inhibitors SnPP and Keto both caused PER2∷LUC
rhythms to damp, SnPP but not Keto potentiated heme’s effect on damping. This apparent
discrepancy could be due to non-specific effects of SnPP. For instance, SnPP has been reported
to inhibit nitric oxide synthase (Grundemar and Ny, 1997), and nitric oxide can bind to REVERB and suppress its inhibitory effect on target gene transcription (Pardee et al., 2009). Thus,
if heme affects rhythms by activating REVERB (Raghuram et al., 2007, Yin et al., 2007), then
SnPP could further enhance heme’s effects by reducing NO levels that tonically inhibit REVERB activity. Alternately, SnPP, which is structurally identical to heme except for the central
metal atom, could mimic heme by binding to similar sites and by activating similar biological
processes.
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Heme and HO inhibitor treatments are expected to respectively increase and decrease levels
of the heme metabolites biliverdin, carbon monoxide, and iron, all of which could potentially
alter clock function (Pinero and Connor, 2000, Barañano et al., 2001, Dioum et al., 2002).
However, our results suggest that the effects of exogenous heme on rhythm damping were not
mediated by these metabolites. Iron clearly had no effect on SCN luminescence rhythms. Since
the volume of media in our cultures was large relative to the amount of tissue in our explants,
it is unlikely that the tissue was capable of metabolizing a significant fraction of exogenous
heme, and it is thus unlikely that biliverdin concentrations in any of our heme-treated cultures
approached 30 μM. Therefore, the effect of heme is most likely independent of the effect we
observed with 30 μM biliverdin. Consistent with this conclusion, 3 μM heme but not 3 μM
biliverdin damped PER2∷LUC rhythms. The lack of an effect of iron and 3 μM biliverdin
treatments is not likely due to a failure of those compounds to cross the plasma membrane.
The concentration of Fe(NH4)2(SO4)2 used (30 μM) would be expected to elevate intracellular
iron levels to at least 4.5-6 μM, based on analysis of rat brain slices treated briefly with a similar
compound (Oubidar et al., 1996). Biliverdin has likewise been reported to readily enter the
cytosol (Shu et al., 2009). We found that treating SCN explants with up to 100 μM CO did not
affect PER2∷LUCIFERASE rhythms relative to controls cultured under the same conditions.
However, since these conditions were detrimental to tissue health, more work is necessary to
conclusively rule out a role for CO in the circadian clock.
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Yamaguchi and colleagues (2003) found that prolonged blockade of sodium-dependent action
potentials in the SCN both caused rhythms in individual cells to damp and caused rhythms
across the SCN to become desynchronized (Yamaguchi et al., 2003), suggesting that
intercellular coupling and stable intracellular rhythms may be related. At the same time, SCN
neurons are capable of maintaining circadian electrical rhythms in isolation (Welsh et al.,
1995), and cells in SCN slices can remain rhythmic even under conditions in which they are
desynchronized (Ohta et al., 2005, Ciarleglio et al., 2009). Heme could thus function by
desynchronizing stable single-cell PER2 rhythms, by damping rhythms in individual cells, or
by a combination of these effects. Consistent with the latter two possibilities, we found that
heme decreased baseline luminescence (Fig. 2); this effect is not likely due to an effect of heme
on LUC activity, since we observed no effect of heme on baseline LUC activity in esophagus
and thymus. Since desynchronization of individual oscillators would not be expected to alter
baseline PER2 expression, the effect of heme on baseline luminescence suggests that heme
probably does not merely cause individual cellular clocks to become uncoupled; rather, heme
likely affects some process that causes overall PER2∷LUC expression levels to decrease.
Single-cell imaging will be necessary to confirm this result and to determine definitively how
heme affects coupling between single-cell clocks in the SCN.
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One concern is that the effects observed here are due to heme’s neurotoxicity (Goldstein et al.,
2003). However, heme neurotoxicity can be mimicked by inorganic iron and blocked by cotreatment with SnPP, suggesting that neurotoxicity associated with heme treatment is due to
release of inorganic iron and subsequent generation of reactive oxygen species (ROSs;
Goldstein et al., 2003). Since heme’s effects on PER2∷LUC damping could not be mimicked
by iron and were potentiated by SnPP, it is unlikely that heme neurotoxicity underlies the
effects observed here. This conclusion is supported by our findings that heme-treated and
control SCNs had equally robust PER2∷LUC rhythms following a media change. Nonetheless,
heme could generate sub-toxic concentrations of ROSs; consistent with this possibility, we
found that under the more stressful culture conditions required for CO treatment, heme
accelerated tissue death or irreversibly disrupted PER2∷LUCIFERASE rhythms (data not
shown). While ROSs have traditionally been viewed as toxic biproducts of cellular function,
they may also be important intracellular and intercellular signaling molecules (Thannickal and
Fanburg, 2000). For instance, MAPK signaling and Ca2+ release from ryanodine-sensitive
stores both appear to be involved in clock function (Ikeda et al., 2003, Akashi et al., 2008) and
are both regulated by ROSs (Hidalgo et al., 2005, Muñoz et al., 2006). It is thus possible that
heme could affect circadian clock function through generation of sub-toxic concentrations of
ROSs and that ROSs could be important in circadian clock function even under physiological,
non-pathological conditions.
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Heme could also act through several other mechanisms to affect SCN clock function (Fig. 8).
In immortalized cell lines, heme has been shown to bind directly to human PER2 to induce its
degradation in the proteasome (Yang et al., 2008). While the lack of an effect of heme on
esophagus and thymus rhythms argues against a direct effect on PER2, heme could affect PER2
levels indirectly through other mechanisms. For instance, heme could affect the SCN circadian
clock by acting on TLR4 (Figueiredo et al., 2007) either directly on clock cells or on resident
microglia. This possibility initially appeared plausible in light of the findings that systemic
LPS administration suppressed Per2 expression and behavioral rhythms (Okada et al., 2008)
and that TNFα, a downstream mediator of TLR4 activation, altered clock gene expression in
vitro and in vivo, reduced the amplitude of behavioral circadian rhythms, and altered SCN
neuronal activity (Cavadini et al., 2007,Nygård et al., 2009). However, since we failed to
observe effects of LPS and TNFα on SCN PER2∷LUC rhythms, those molecules probably do
not mediate heme’s effect on damping. Heme can also block BK channels (Tang et al.,
2003), which are known to be important for maintaining robust SCN electrophysiological
rhythms in vitro and normal behavioral rhythms in vivo (Meredith et al., 2006). However,
relative to wild-type mice, BK channel knockout mice do not show less robust rhythms of SCN
Per2 expression in vivo (Meredith et al., 2006), while heme has clear effects on PER2 rhythms
in vitro.
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Finally, heme could suppress Bmal1 expression by activating the REV-ERBs (Raghuram et
al., 2007, Yin et al., 2007), functionally mimicking the effect of Bmal1 knockout, which
abolishes SCN mPer2 transcript rhythms in vivo and fibroblast PER2∷LUC rhythms in vitro
(Bunger et al., 2000, Liu et al., 2008). Consistent with this hypothesis, the inducible
overexpression of Rev-erbα in liver explants of a transgenic mouse line decreased Bmal1
expression and abolished PER2∷LUC rhythms (Kornmann et al., 2007). However, since
BMAL1 in turn regulates Rev-erbα expression (Preitner et al., 2002, Triqueneaux et al.,
2004), the effects of endogenous REV-ERB over-activity on molecular oscillator function are
unclear. In this context, the slow time course of heme’s effects on PER2∷LUC rhythms could
be due to the general robustness of clock function in the face of molecular perturbation (Liu
et al., 2007). While the reason heme had no effect on rhythms in esophagus and thymus is not
clear, one possibility is that heme’s downstream effector may function in a tissue-specific
manner. For instance, the RORs, transcriptional activators that compete with the REV-ERBs
for binding to the Bmal1 promoter, are expressed tissue-specifically (Sato et al., 2004,
Neuroscience. Author manuscript; available in PMC 2010 December 1.
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Guillaumond et al., 2005, Ko and Takahashi, 2006, Liu et al., 2008) and could modulate hemebound REV-ERB’s ability to suppress clock gene expression. Further studies are clearly
necessary to understand how heme affects SCN PER2∷LUC rhythms.
Both pharmacological heme depletion and a REV-ERB point mutation that prevents heme
binding inhibit REV-ERB-mediated transcriptional repression in cell lines (Raghuram et al.,
2007, Yin et al., 2007), suggesting that basal heme levels must be sufficient to activate REVERB. Given that the heme-REV-ERB dissociation constant has been estimated as 2-6 μM
(Raghuram et al., 2007, Pardee et al., 2009), it is not unreasonable to assume that intracellular
free heme concentrations in the SCN may be in the low micromolar range. Since as little as 3
μM heme was found to damp rhythms in the present study, it is likely that the effects observed
here are physiologically relevant.
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We found that inhibiting heme synthesis with NMP did not cause SCN rhythms to damp relative
to controls, although the difference in damping between 30 μM heme and NMP groups only
approached significance (see Results). Since heme is essential for many critical cellular
processes, it is impossible to completely deplete heme without compromising tissue viability.
Since 1 μM NMP decreased heme levels in primary rat hepatocytes by about 40% (Jacobs et
al., 1998), we anticipate that the 10-50 μM NMP used in the present study induced substantial
heme deficiency. The lack of a clear effect of NMP on rhythm damping would not be
unexpected if heme’s effects on rhythms are mediated by REV-ERB, since the REV-ERBs
themselves are dispensable for PER2∷LUC rhythmicity (Liu et al., 2008). Regardless, the
lengthening of circadian period by NMP is consistent with an important role for heme in the
circadian system. Of particular interest is that possibility that heme could be involved in
determining the phases of gene expression rhythms, for which the REV-ERBs are thought to
be essential (Liu et al., 2008, Ukai-Tadenuma et al., 2008). Broad transcriptional profiling of
cells or tissues treated with heme will be necessary to test this possibility.
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The findings that the circadian clock regulates expression of the gene for the rate-limiting
enzyme (5-aminolevulinc acid synthetase 1) in heme synthesis (Alas1; (Zheng et al., 2001) and
that heme oxygenase activity varies across the circadian cycle (Rubio et al., 2003) have led to
speculation that heme levels may oscillate in a circadian manner. Heme could therefore
participate in a novel feedback loop wherein CLOCK/NPAS2:BMAL1 drives expression of
Alas1 and thus synthesis of heme, which could feed back to inhibit Bmal1 expression via REVERB. Since REV-ERB/heme regulate expression of several metabolic genes and since heme
is synthesized from the Krebs cycle intermediate succinyl CoA, heme could be involved in
coupling the circadian clock and metabolism (Raghuram et al., 2007, Yin et al., 2007). From
the clinical perspective, regulation of heme catabolism by cytokines (Wagener et al., 2003)
could underlie the circadian disruption associated with elevated cytokine levels in conditions
such as cancer-related fatigue (Coogan and Wyse, 2008), and abnormal heme homeostasis
associated with Alzheimer’s disease and aging (Atamna et al., 2002, Dwyer et al., 2009) could
be involved in the circadian system disturbance observed in those conditions (Wu and Swaab,
2007). As other authors have proposed (Kaasik and Lee, 2004), the ability of heme to alter
SCN function could also lead to the development of treatments for circadian system
disturbance.
While heme’s role as a cofactor necessary for the function of a large number of proteins and
enzymes has been well-established, more recent work has suggested that heme could be an
important signaling molecule in the brain. Indeed, heme could have wide-ranging effects on
neuronal physiology through its abilities to regulate gene expression (Raghuram et al., 2007,
Yin et al., 2007), potassium currents (Tang et al., 2003), and protein stability (Yang et al.,
2008). However, evidence of an essential role for heme signaling in any neural process has
been lacking. Our data suggest that heme homeostasis is necessary for normal circadian clock
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function and that heme could be an important component of the circadian clock in mammals.
Based on our findings, additional studies of heme’s precise role in the circadian system and of
possible roles for heme in regulating other aspects of neural function are clearly warranted.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

NIH-PA Author Manuscript

Effects of heme on PER2∷LUC rhythms in mouse SCN explants. A, B Three representative
raw bioluminescence traces (A) and all baseline-subtracted, smoothed data (B) for SCNs
treated with 0-100 μM heme (left panels in B); cultures were subsequently washed and
transferred to control media at the time indicated by the downward arrows in A, and
bioluminescence monitoring was continued (right panels in B). Tissue was dissected on day 0
(not shown). In B, each heatmap row represents a different culture, the x-axis indicates time
(with t = 1 corresponding to the time of peak luminescence on day 1 in the left panels and to
the time of peak luminescence on the day following the media change in the right panels),
colors represent luminescence level as indicated in the key to the right, pre- and post-media
change data were normalized independently, and colored dots indicate the cultures illustrated
by traces in part A. C, Mean peak PER2:LUC expression during each circadian cycle prior to
the media change, normalized to peak expression on the day after dissection (Cycle 1). D, Mean
damping constants for recordings prior to the media change. In this and subsequent figures:
groups with the same letters above error bars are statistically similar while groups with different
letters are statistically different (Tukey’s HSD, p’s < .05); all error bars indicate ±SEM.
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Figure 2.

Effects of heme treatment on baseline luminescence in SCN explants from PER2∷LUC knockin
mice. A, Example of a baseline (solid line) calculated as the 24 h. running average of the raw
data (points) for a control SCN (left) and an SCN treated with 3 μM heme (right). B, Mean
normalized baseline luminescence for control SCNs (0 μM, light gray line) and SCNs treated
with 3 μM (dark gray line) or 30 μM (black line) heme binned every six hours. Horizontal lines
indicate where 3 μM heme-treated (solid) and 30 μM heme-treated (dashed) groups differ
statistically (p < .05) from the control (0 μM) group (one-way ANOVAs at each time point
with Bonferroni correction, followed by Tukey’s HSD).
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Figure 3.

Mean damping constants for control SCN explants (gray bar) and SCN explants treated with
heme (black bar) or with the control porphyrin PPIX (open bar). Data for control and 30 μM
heme groups are repeated from Fig. 1.
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Figure 4.
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Effects of heme oxygenase inhibitors on PER2∷LUCIFERASE rhythms in mouse SCN
explants. A, Representative raw bioluminescence data for SCNs treated with 10 μM
ketoconazole (Keto) or 30 μM tin protoporphyrin IX (SnPP). B, Damping constants for SCN
cultures treated with Keto (black bars), SnPP (gray bars), or no HO inhibitors (open bars) in
the presence or absence of heme (x-axis). Data for control and 30 μM heme groups are repeated
from Fig. 1.

NIH-PA Author Manuscript
Neuroscience. Author manuscript; available in PMC 2010 December 1.

Guenthner et al.

Page 17

NIH-PA Author Manuscript
Figure 5.

Damping constants of PER2∷LUC rhythms from control peripheral tissue explants and from
peripheral tissue explants treated with 30 μM SnPP, 30 μM heme, or both together. Each tissue
was analyzed independently, and letters above bars refer only to comparisons within a tissue.
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Figure 6.

Effects of heme metabolites on SCN PER2∷LUCIFERASE rhythms. A, C, Representative raw
luminescence traces for SCN cultures treated with 30 μM iron or 30 μM biliverdin (A) or with
air or 100 μM carbon monoxide (C). B, D, Mean damping constants for SCNs treated with
iron or biliverdin (B) or with air or CO (D) as indicated in figure keys. In B, data for control
and 30 μM heme groups are repeated from Fig. 1. (*, significantly different from controls, p
< .05)
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Figure 7.
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A, Representative raw bioluminescence traces for SCNs treated with 50 μM Nmethylprotoporphyrin IX (NMP). B, Damping constants for SCNs treated with 10 μM or 50
μM NMP, as well as for control SCNs and SCNs treated with 30 μM heme (reproduced from
Fig. 1). (*, significantly different from controls, p < .05) NMP also had a significant effect on
circadian period (see Supplementary Table).
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Figure 8.
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Schematic of the circadian clock mechanism and the possible sites where heme may act to
affect rhythms. CLOCK:BMAL1 or NPAS2:BMAL1 bind to E-boxes to drive expression of
circadian genes; two families of those, the Per and Cry genes, dimerize and inhibit CLOCK/
NPAS2:BMAL1-mediated transcription; the REV-ERBs feedback to inhibit Bmal1 expression
by binding to a ROR element in the Bmal1 promoter. Expression of the rate-limiting enzyme
in heme synthesis, Alas1, is also circadianly regulated by NPAS2:BMAL1, while the
metabolism of heme to Fe2+. biliverdin, and CO by heme oxygenase (HO) is regulated at the
post-translational level. Heme could affect rhythms by increasing PER protein degradation,
inhibiting BK channels, or enhancing transcriptional repression by the REV-ERBs. Heme can
also bind to toll-like receptor 4 (TLR4), perhaps on clock cells or on resident microglia, and
induce downstream effects through MAPK and NFκB signaling; TNFα secretion induced by
TLR4 stimulation could also feedback to affect clock cell function through those same two
signaling pathways. CO could affect rhythms by decreasing NPAS2-dependent transcription,
by promoting cGMP production, or by stimulating BK channels. Biliverdin is rapidly degraded
to bilirubin, and both biliverdin and bilirubin could affect rhythms by altering the overall
cellular oxidation state. Fe2+ could be involved in the generation of reactive oxygen species
(ROSs) that could affect diverse cellular processes. Our results rule out a role for TLR4/
TNFα in heme’s effect, while the lack of an effect of heme on esophagus and thymus rhythms
argues against a direct effect of heme on PER2 degradation; in addition, we found no evidence
that heme’s effects are mediated by its degradation products.
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